Due to the important role of TGF-β signaling in the immune excluded phenotype, and the improved T-cell migration attained upon blockade of TGF-β signaling in murine models of cancer, this signaling pathway represents an attractive option for therapeutic intervention [69,70]. The gene discussed is TGFB1; the disease is cancer.